1. Home
  2. XBIT vs ICG Comparison

XBIT vs ICG Comparison

Compare XBIT & ICG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo XBiotech Inc.

XBIT

XBiotech Inc.

HOLD

Current Price

$2.41

Market Cap

75.0M

Sector

Health Care

ML Signal

HOLD

Logo Intchains Group Limited

ICG

Intchains Group Limited

HOLD

Current Price

$1.08

Market Cap

69.2M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
XBIT
ICG
Founded
2005
2017
Country
United States
China
Employees
N/A
127
Industry
Pharmaceuticals and Biotechnology
Semiconductors
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
75.0M
69.2M
IPO Year
2015
2022

Fundamental Metrics

Financial Performance
Metric
XBIT
ICG
Price
$2.41
$1.08
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$5.25
AVG Volume (30 Days)
21.3K
67.1K
Earning Date
05-08-2026
05-21-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$6.80
Revenue Growth
N/A
N/A
52 Week Low
$2.09
$0.93
52 Week High
$3.61
$3.22

Technical Indicators

Market Signals
Indicator
XBIT
ICG
Relative Strength Index (RSI) 38.96 35.24
Support Level $2.35 $0.93
Resistance Level $2.41 $1.36
Average True Range (ATR) 0.06 0.10
MACD -0.02 -0.02
Stochastic Oscillator 4.00 10.00

Price Performance

Historical Comparison
XBIT
ICG

About XBIT XBiotech Inc.

XBiotech Inc is a biopharmaceutical company that discovers and develops True Human monoclonal antibodies derived from human donors to replicate the human immune response in the treatment of various diseases. It has developed a pipeline of product candidates using True Human antibodies targeting both inflammatory and infectious diseases. The company's developement pipeline comprises: Natrunix, an antibody targeting IL-1a in oncology (pancreatic cancer), a clinical stage therapeutic for Methicillin Resistant Staphylococcus aureus (MRSA), and several pre-clinical stage therapeutics, including: an oral delivery antibody therapeutic for colon infection by C. difficile; an injectable therapy for varicella zoster (adult chicken pox), the causative agent for shingles; and an influenza therapy.

About ICG Intchains Group Limited

Intchains Group Ltd is an inventive altcoins development company that engages in the provision of altcoin mining products, the strategic acquisition and holding of Ethereum-based cryptocurrencies and the active development of inventive Web3 applications. The company offers high-performance mining products including altcoin mining machines incorporating its ASIC chips that have high computing power and superior power efficiency, ASIC chips and ancillary software and hardware, all of which cater to the evolving needs of the blockchain industry. Geographically, it operates in Mainland China, Hong Kong, and Other countries or regions.

Share on Social Networks: